glyburide has been researched along with Diabetes Mellitus, Type 1 in 67 studies
Glyburide: An antidiabetic sulfonylurea derivative with actions like those of chlorpropamide
glyburide : An N-sulfonylurea that is acetohexamide in which the acetyl group is replaced by a 2-(5-chloro-2-methoxybenzamido)ethyl group.
Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Right atrial sections from four patient groups-non-diabetic, insulin-dependent diabetes mellitus (IDDM), non-insulin-dependent diabetes mellitus (NIDDM) receiving glibenclamide, and NIDDM receiving metformin-were subjected to one of the following protocols: aerobic control, simulated ischemia/reoxygenation, ischemic preconditioning before ischemia, and pharmacological preconditioning with alpha 1 agonist phenylephrine, adenosine, the mito-K(ATP) channel opener diazoxide, the protein kinase C (PKC) activator phorbol-12-myristate-13-acetate (PMA), or the p38 mitogen-activated protein kinase (p38MAPK) activator anisomycin." | 3.73 | Mitochondrial dysfunction as the cause of the failure to precondition the diabetic human myocardium. ( Fowler, A; Galiñanes, M; Hassouna, A; Loubani, M; Matata, BM; Standen, NB, 2006) |
| "Glyburide and other sulfonylureas consistently enhance receptor binding in cells from patients with non-insulin-dependent diabetes mellitus, whereas no effects and mixed effects have been demonstrated in cells from patients with insulin-dependent diabetes mellitus and in normal cells, respectively." | 3.67 | Dual actions of sulfonylureas and glyburide. Receptor and post-receptor effects. ( Gavin, JR, 1985) |
| "Alterations in plasma branched-chain amino acids (valine, isoleucine and leucine) and alanine have been described in patients with insulin-dependent diabetes mellitus who have poor metabolic control." | 3.66 | Branched-chain amino acids and alanine as indices of the metabolic control in type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic patients. ( Angiolini, A; Ciavarella, A; Forlani, G; Marchesini, G; Pisi, E; Vannini, P; Zoli, M, 1982) |
| " Therefore, it is apparent that the addition of glibenclamide to insulin reduces daily insulin dosage and renders a greater uniformity to diurnal blood glucose control, most probably secondary to enhancement of insulin sensitivity." | 2.68 | More uniform diurnal blood glucose control and a reduction in daily insulin dosage on addition of glibenclamide to insulin in type 1 diabetes mellitus: role of enhanced insulin sensitivity. ( Birkenholz, M; Kabadi, M; Kabadi, UM; McCoy, S, 1995) |
| "Neonatal diabetes mellitus is rare, may either be transient or permanent, and may be caused by mutations in any of the several different genes." | 1.35 | Outpatient transition of an infant with permanent neonatal diabetes due to a KCNJ11 activating mutation from subcutaneous insulin to oral glyburide. ( Bremer, AA; Lustig, RH; Ranadive, S, 2008) |
| " Dosing of glyburide three times daily was critical for her successful transition." | 1.34 | Transition from insulin to glyburide in a 4-month-old girl with neonatal diabetes mellitus caused by a mutation in KCNJ11. ( Chan, YM; Laffel, LM, 2007) |
| "Significantly more participants with type 2 diabetes using oral drugs than those with type 1 diabetes and using insulin preferred inhaled insulin (98." | 1.33 | Willingness to pay for inhaled insulin: a contingent valuation approach. ( Einarson, TR; Leiter, LA; MacKeigan, LD; Sadri, H, 2005) |
| "IDDM was induced in rats by streptozotocin (STZ) injection, and adequate insulin was provided to maintain moderate hyperglycemia." | 1.31 | Exaggerated impact of ATP-sensitive K(+) channels on afferent arteriolar diameter in diabetes mellitus. ( Bast, JP; Carmines, PK; Fallet, RW; Ikenaga, H, 2000) |
| " Old age, maximum dosage of glibenclamide (15 mg/day) and multimorbidity were characteristic of these patients." | 1.29 | [Incidence of severe hypoglycemia in relation to metabolic control and patient knowledge]. ( Ratzmann, KP; Schimke, E, 1995) |
| "In protocol 1, 10 patients with NIDDM and seven young healthy control subjects were studied." | 1.28 | Effects of glyburide on in vivo insulin-mediated glucose disposal. ( Simonson, DC, 1990) |
| "In the IDDM patients, the addition of glyburide produced no change in daily insulin dose (54 +/- 8 vs." | 1.27 | Effect of glyburide on glycemic control, insulin requirement, and glucose metabolism in insulin-treated diabetic patients. ( Castellino, P; DeFronzo, RA; Delprato, S; Groop, L; Simonson, DC, 1987) |
| "When treated with glyburide, the severity of the mechanical defect was significantly less." | 1.27 | Effect of chronic sulfonylurea treatment on the myocardium of insulin-dependent diabetic rats. ( Mozaffari, MS; Schaffer, SW; Wilson, GL, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 25 (37.31) | 18.7374 |
| 1990's | 10 (14.93) | 18.2507 |
| 2000's | 20 (29.85) | 29.6817 |
| 2010's | 11 (16.42) | 24.3611 |
| 2020's | 1 (1.49) | 2.80 |
| Authors | Studies |
|---|---|
| He, B | 1 |
| Li, X | 2 |
| Zhou, Z | 1 |
| Heo, JW | 1 |
| Kim, SW | 1 |
| Cho, EH | 1 |
| Babiker, T | 1 |
| Shepherd, MH | 1 |
| Hattersley, AT | 3 |
| Rodríguez-Villar, C | 1 |
| Conget, I | 1 |
| Ferrer-Fàbrega, J | 1 |
| Paredes, D | 1 |
| Ruíz, A | 1 |
| Roque, R | 1 |
| Rull, R | 1 |
| López-Boado, M | 1 |
| Ricart, MJ | 1 |
| Garcia, R | 1 |
| Adalia, R | 1 |
| Rabbone, I | 1 |
| Barbetti, F | 1 |
| Marigliano, M | 1 |
| Bonfanti, R | 1 |
| Piccinno, E | 1 |
| Ortolani, F | 1 |
| Ignaccolo, G | 1 |
| Maffeis, C | 1 |
| Confetto, S | 1 |
| Cerutti, F | 1 |
| Zanfardino, A | 1 |
| Iafusco, D | 1 |
| Cao, B | 1 |
| Gong, C | 1 |
| Wu, D | 1 |
| Lu, C | 1 |
| Liu, F | 1 |
| Liu, X | 1 |
| Zhang, Y | 1 |
| Gu, Y | 2 |
| Qi, Z | 1 |
| Liu, M | 2 |
| Li, W | 1 |
| Su, C | 1 |
| Liang, X | 1 |
| Feng, M | 1 |
| Lamprianou, S | 1 |
| Gysemans, C | 1 |
| Bou Saab, J | 1 |
| Pontes, H | 1 |
| Mathieu, C | 1 |
| Meda, P | 1 |
| Wagner, VM | 1 |
| Kremke, B | 1 |
| Hiort, O | 1 |
| Flanagan, SE | 1 |
| Pearson, ER | 1 |
| Støy, J | 1 |
| Greeley, SA | 1 |
| Paz, VP | 1 |
| Ye, H | 1 |
| Pastore, AN | 1 |
| Skowron, KB | 1 |
| Lipton, RB | 1 |
| Cogen, FR | 1 |
| Bell, GI | 1 |
| Philipson, LH | 1 |
| Esmatjes, E | 1 |
| Jimenez, A | 1 |
| Diaz, G | 1 |
| Mora, M | 1 |
| Casamitjana, R | 1 |
| Pérez de Nanclares, G | 1 |
| Castaño, L | 1 |
| José Ricart, M | 1 |
| Lauridsen, MH | 1 |
| Boesgaard, TW | 1 |
| Pedersen, OB | 1 |
| Hansen, T | 1 |
| Hertz, B | 1 |
| Mohamadi, A | 1 |
| Clark, LM | 1 |
| Lipkin, PH | 1 |
| Mahone, EM | 1 |
| Wodka, EL | 1 |
| Plotnick, LP | 1 |
| Ting, WH | 1 |
| Huang, CY | 1 |
| Lo, FS | 1 |
| Lee, HC | 1 |
| Lin, CL | 1 |
| Guo, WL | 1 |
| Lee, YJ | 1 |
| Jones, AG | 1 |
| D'Aleo, V | 1 |
| Del Guerra, S | 1 |
| Groves, C | 1 |
| Lupi, R | 1 |
| Tancredi, M | 1 |
| McCarthy, M | 1 |
| Marchetti, P | 1 |
| Ballas, J | 1 |
| Moore, TR | 1 |
| Ramos, GA | 1 |
| Sang, Y | 1 |
| Ni, G | 1 |
| Cabrera-Rode, E | 1 |
| Perich, P | 1 |
| Diaz-Horta, O | 1 |
| Tiberti, C | 1 |
| Molina, G | 1 |
| Arranz, C | 1 |
| Martin, JM | 1 |
| Licea, M | 1 |
| De Leiva, AD | 1 |
| Puig-Domingo, M | 1 |
| Dimario, U | 1 |
| Østergård, T | 1 |
| Degn, KB | 1 |
| Gall, MA | 1 |
| Carr, RD | 1 |
| Veldhuis, JD | 1 |
| Thomsen, MK | 1 |
| Rizza, RA | 1 |
| Schmitz, O | 1 |
| Riddle, MC | 2 |
| Codner, E | 1 |
| Flanagan, S | 1 |
| Ellard, S | 1 |
| García, H | 1 |
| Bisseling, TM | 1 |
| Versteegen, MG | 1 |
| van der Wal, S | 1 |
| Copius Peereboom-Stegeman, JJ | 1 |
| Borggreven, JM | 1 |
| Steegers, EA | 1 |
| van der Laak, JA | 1 |
| Russel, FG | 1 |
| Smits, P | 1 |
| Koster, JC | 1 |
| Remedi, MS | 1 |
| Dao, C | 1 |
| Nichols, CG | 1 |
| Hassouna, A | 1 |
| Loubani, M | 1 |
| Matata, BM | 1 |
| Fowler, A | 1 |
| Standen, NB | 1 |
| Galiñanes, M | 1 |
| Sadri, H | 1 |
| MacKeigan, LD | 1 |
| Leiter, LA | 1 |
| Einarson, TR | 1 |
| Chan, YM | 1 |
| Laffel, LM | 1 |
| Letha, S | 1 |
| Mammen, D | 1 |
| Valamparampil, JJ | 1 |
| Bremer, AA | 1 |
| Ranadive, S | 1 |
| Lustig, RH | 1 |
| Bieger, WP | 1 |
| Dlugosch, R | 1 |
| Rettenmeier, A | 1 |
| Holler, HD | 1 |
| Bert, H | 1 |
| Schwarz, W | 1 |
| Fiehn, W | 1 |
| Merkt, J | 1 |
| Weicker, H | 1 |
| Burke, BJ | 2 |
| Hartog, M | 1 |
| Waterfield, MR | 1 |
| Vannini, P | 1 |
| Marchesini, G | 1 |
| Forlani, G | 1 |
| Angiolini, A | 1 |
| Ciavarella, A | 1 |
| Zoli, M | 1 |
| Pisi, E | 1 |
| Ratzmann, KP | 1 |
| Schimke, E | 1 |
| Olsen, KM | 1 |
| Kearns, GL | 1 |
| Kemp, SF | 1 |
| Hauner, H | 1 |
| Ziegler, O | 1 |
| Guerci, B | 1 |
| Algan, M | 1 |
| Lonchamp, P | 1 |
| Weber, M | 1 |
| Drouin, P | 1 |
| Kabadi, UM | 1 |
| McCoy, S | 1 |
| Birkenholz, M | 1 |
| Kabadi, M | 1 |
| Ladis, V | 1 |
| Theodorides, C | 1 |
| Palamidou, F | 1 |
| Frissiras, S | 1 |
| Berdousi, H | 1 |
| Kattamis, C | 1 |
| Sharma, A | 1 |
| Kharb, S | 1 |
| Chugh, SN | 1 |
| Kakkar, R | 1 |
| Singh, GP | 1 |
| Sasakuma, F | 1 |
| Shimizu, T | 1 |
| Wada, H | 1 |
| Morii, T | 1 |
| Sasaki, A | 1 |
| Ehara, M | 1 |
| Ikenaga, H | 1 |
| Bast, JP | 1 |
| Fallet, RW | 1 |
| Carmines, PK | 1 |
| Fedorchenko, IuL | 1 |
| Goncharova, EN | 1 |
| Koblova, NM | 1 |
| Fallucca, F | 1 |
| Iavicoli, M | 1 |
| Menzinger, G | 1 |
| Mirabella, C | 1 |
| Andreani, D | 1 |
| Willms, B | 1 |
| Wildenhoff, KE | 1 |
| Beischer, W | 1 |
| Heinze, E | 1 |
| Keller, L | 1 |
| Raptis, S | 1 |
| Kerner, W | 1 |
| Pfeiffer, EF | 1 |
| Atiea, JA | 1 |
| Luzio, S | 1 |
| Owens, DR | 1 |
| Gums, JG | 1 |
| Curry, RW | 1 |
| Montes de Oca, G | 1 |
| Skluth, HA | 1 |
| Reynolds, LR | 1 |
| Stålhammar, J | 1 |
| Bergman, U | 1 |
| Boman, K | 1 |
| Dahlén, M | 1 |
| Simonson, DC | 2 |
| Hart, JS | 1 |
| Bouma, DJ | 1 |
| Phillipson, BE | 1 |
| Youker, G | 1 |
| Khristov, V | 1 |
| Nikolov, M | 1 |
| Delprato, S | 1 |
| Castellino, P | 1 |
| Groop, L | 1 |
| DeFronzo, RA | 1 |
| Garrel, DR | 1 |
| Picq, R | 1 |
| Bajard, L | 1 |
| Harfouche, M | 1 |
| Tourniaire, J | 1 |
| Larkins, RG | 1 |
| Jerums, G | 1 |
| Taft, JL | 1 |
| Godfrey, H | 1 |
| Smith, IL | 1 |
| Martin, TJ | 1 |
| Stocks, AE | 1 |
| Ma, A | 1 |
| Howlett, V | 1 |
| Cameron, DP | 1 |
| Mozaffari, MS | 1 |
| Wilson, GL | 1 |
| Schaffer, SW | 1 |
| Pernet, A | 1 |
| Trimble, ER | 1 |
| Kuntschen, F | 1 |
| Assal, JP | 1 |
| Hahn, C | 1 |
| Renold, AE | 1 |
| Gerich, JE | 1 |
| Gavin, JR | 1 |
| Kostner, GM | 1 |
| Schernthaner, G | 1 |
| Tattersall, RB | 1 |
| Cicognani, A | 1 |
| Tassoni, P | 1 |
| Pirazzoli, P | 1 |
| Collina, A | 1 |
| Cacciari, E | 1 |
| Weber, B | 2 |
| Stratmann, FW | 1 |
4 reviews available for glyburide and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Continuous spectrum of glucose dysmetabolism due to the KCNJ11 gene mutation-Case reports and review of the literature.
Topics: Adolescent; Base Sequence; Blood Glucose; Child; Diabetes Mellitus, Type 1; DNA Mutational Analysis; | 2021 |
Management of diabetes in pregnancy.
Topics: Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes, Gestational; Female; Glyburide; Huma | 2012 |
Timely initiation of basal insulin.
Topics: Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Disease Progression; Drug Therapy, Combination | 2004 |
Sulfonylureas in the treatment of diabetes mellitus--1985.
Topics: Blood Glucose; Body Weight; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Drug Therapy, Comb | 1985 |
12 trials available for glyburide and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Slowly progressing type 1 diabetes: persistence of islet cell autoantibodies is related to glibenclamide treatment.
Topics: Autoantibodies; Blood Glucose; Body Mass Index; C-Peptide; Diabetes Mellitus, Type 1; Diabetes Melli | 2002 |
The insulin secretagogues glibenclamide and repaglinide do not influence growth hormone secretion in humans but stimulate glucagon secretion during profound insulin deficiency.
Topics: Blood Glucose; C-Peptide; Carbamates; Diabetes Mellitus, Type 1; Fatty Acids, Nonesterified; Glucago | 2004 |
Trial of sulfonylurea in combination with insulin in the therapy of diabetes type I and II. Evidence against a primary extrapancreatic receptor effect.
Topics: Adult; Binding, Competitive; Blood Glucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Do | 1984 |
Improved diabetic control in insulin-dependent diabetics treated with insulin and glibenclamide.
Topics: Adult; Blood Glucose; C-Peptide; Clinical Trials as Topic; Diabetes Mellitus, Type 1; Double-Blind M | 1984 |
More uniform diurnal blood glucose control and a reduction in daily insulin dosage on addition of glibenclamide to insulin in type 1 diabetes mellitus: role of enhanced insulin sensitivity.
Topics: Adult; Aged; Blood Glucose; Body Weight; C-Peptide; Cholesterol; Circadian Rhythm; Cross-Over Studie | 1995 |
Evaluation of oxidative stress before and after control of glycemia and after vitamin E supplementation in diabetic patients.
Topics: Adult; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Femal | 2000 |
Treatment of type I diabetes with a combination of glyburide and insulin.
Topics: Adolescent; Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 1; Double-Blind Method; Drug Therapy | 1992 |
Efficacy of bedtime NPH insulin with daytime sulfonylurea for subpopulation of type II diabetic subjects.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Clinical Trials as Topic; Diabetes Mellitus, Type 1; Double-B | 1989 |
Lack of effect of gliclazide on platelet aggregation in insulin-treated and non-insulin-treated diabetes: a two-year controlled study.
Topics: Clinical Trials as Topic; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathie | 1988 |
Lack of effect of glibenclamide on insulin requirements and diabetic control in persons with insulin-dependent diabetes.
Topics: Adult; Blood Glucose; Clinical Trials as Topic; Diabetes Mellitus, Type 1; Double-Blind Method; Drug | 1988 |
Sulphonylurea and insulin: combined treatment in type 1 (insulin-dependent) diabetes.
Topics: C-Peptide; Clinical Trials as Topic; Diabetes Mellitus, Type 1; Double-Blind Method; Drug Therapy, C | 1985 |
Oral substitutes for insulin: modern appraisal of their action and indications.
Topics: Adolescent; Adult; Aged; Animals; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diet, | 1972 |
51 other studies available for glyburide and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Unsuccessful switch from insulin to sulfonylurea therapy in permanent neonatal diabetes mellitus due to an R201H mutation in the KCNJ11 gene: a case report.
Topics: Administration, Oral; Adolescent; Arginine; Blood Glucose; Diabetes Mellitus, Type 1; Glyburide; Gly | 2013 |
Continue with long term sulfonylureas in patients with mutations in the KCNJ11 gene when there is evidence of response even if insulin treatment is still required.
Topics: Diabetes Mellitus, Type 1; Glyburide; Humans; Hypoglycemic Agents; Insulin; Male; Mutation, Missense | 2013 |
Successful Pancreas Transplantation From a Deceased Donor Intoxicated With Oral Antidiabetic Agent: A Case Report.
Topics: Diabetes Mellitus, Type 1; Diabetic Nephropathies; Drug Overdose; Female; Glyburide; Humans; Hypogly | 2015 |
Successful treatment of young infants presenting neonatal diabetes mellitus with continuous subcutaneous insulin infusion before genetic diagnosis.
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus; Diabetes Mellitus, Type 1; Female; Glyburide; Humans; H | 2016 |
Genetic Analysis and Follow-Up of 25 Neonatal Diabetes Mellitus Patients in China.
Topics: Blood Glucose; China; Diabetes Mellitus, Type 1; Female; Follow-Up Studies; Genotype; Glyburide; Gly | 2016 |
Glibenclamide Prevents Diabetes in NOD Mice.
Topics: Animals; Cells, Cultured; Cytokines; Diabetes Mellitus, Type 1; Female; Glyburide; Hypoglycemic Agen | 2016 |
Transition from insulin to sulfonylurea in a child with diabetes due to a mutation in KCNJ11 encoding Kir6.2--initial and long-term response to sulfonylurea therapy.
Topics: Blood Glucose; Child; Diabetes Mellitus, Type 1; Glyburide; Glycated Hemoglobin; Heterozygote; Human | 2009 |
Diagnosis and treatment of neonatal diabetes: a United States experience.
Topics: Adolescent; Adult; ATP-Binding Cassette Transporters; Child; Child, Preschool; Diabetes Complication | 2008 |
Neonatal diabetes with end-stage nephropathy: pancreas transplantation decision.
Topics: Adult; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Follow-Up Studies; Glyburide; Humans; Hypo | 2008 |
[Diabetes in infants may be treated with sulfonylurea as a replacement for insulin].
Topics: Child, Preschool; Diabetes Mellitus, Type 1; Diabetic Ketoacidosis; Female; Glyburide; Humans; Hypog | 2009 |
Medical and developmental impact of transition from subcutaneous insulin to oral glyburide in a 15-yr-old boy with neonatal diabetes mellitus and intermediate DEND syndrome: extending the age of KCNJ11 mutation testing in neonatal DM.
Topics: Administration, Oral; Adolescent; Continuity of Patient Care; Developmental Disabilities; Diabetes M | 2010 |
Improved diabetic control during oral sulfonylurea treatment in two children with permanent neonatal diabetes mellitus.
Topics: Adolescent; Blood Glucose; C-Peptide; Child; Diabetes Mellitus, Type 1; DNA Mutational Analysis; Dru | 2009 |
Reevaluation of a case of type 1 diabetes mellitus diagnosed before 6 months of age.
Topics: Administration, Oral; Adolescent; Amino Acid Substitution; Developmental Disabilities; Diabetes Mell | 2010 |
INS VNTR class genotype and the function of isolated human islets.
Topics: Aged; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Gene Expression Regulation; Gene | 2011 |
AV59M KCNJ11 gene mutation leading to intermediate DEND syndrome in a Chinese child.
Topics: Asian People; Developmental Disabilities; Diabetes Mellitus, Type 1; Glyburide; Humans; Hypoglycemic | 2011 |
High-dose glibenclamide can replace insulin therapy despite transitory diarrhea in early-onset diabetes caused by a novel R201L Kir6.2 mutation.
Topics: Amino Acid Substitution; Diabetes Mellitus, Type 1; Diarrhea; Female; Glyburide; Humans; Hypoglycemi | 2005 |
Impaired KATP channel function in the fetoplacental circulation of patients with type 1 diabetes mellitus.
Topics: 4-Aminopyridine; Charybdotoxin; Diabetes Mellitus, Type 1; Endothelial Cells; Female; Glyburide; Hum | 2005 |
ATP and sulfonylurea sensitivity of mutant ATP-sensitive K+ channels in neonatal diabetes: implications for pharmacogenomic therapy.
Topics: Adenosine Triphosphate; Animals; Cell Line; Diabetes Mellitus, Type 1; Glyburide; Humans; Hypoglycem | 2005 |
Mitochondrial dysfunction as the cause of the failure to precondition the diabetic human myocardium.
Topics: Adenosine; Adrenergic alpha-Agonists; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitu | 2006 |
Willingness to pay for inhaled insulin: a contingent valuation approach.
Topics: Administration, Inhalation; Administration, Oral; Adult; Canada; Diabetes Mellitus, Type 1; Diabetes | 2005 |
Transition from insulin to glyburide in a 4-month-old girl with neonatal diabetes mellitus caused by a mutation in KCNJ11.
Topics: Diabetes Mellitus, Type 1; Female; Glyburide; Humans; Hypoglycemic Agents; Infant; Insulin; Potassiu | 2007 |
Permanent neonatal diabetes due to KCNJ11 gene mutation.
Topics: Acute Kidney Injury; Amino Acid Substitution; Arginine; Blood Glucose; Cysteine; Diabetes Mellitus, | 2007 |
Outpatient transition of an infant with permanent neonatal diabetes due to a KCNJ11 activating mutation from subcutaneous insulin to oral glyburide.
Topics: Birth Weight; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Glybu | 2008 |
Branched-chain amino acids and alanine as indices of the metabolic control in type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic patients.
Topics: Alanine; Amino Acids, Branched-Chain; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Type 1; F | 1982 |
[Incidence of severe hypoglycemia in relation to metabolic control and patient knowledge].
Topics: Adult; Aged; Blood Glucose Self-Monitoring; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Do | 1995 |
Glyburide protein binding and the effect of albumin glycation in children, young adults, and older adults with diabetes.
Topics: Adolescent; Adult; Aged; Blood Glucose; Child; Child, Preschool; Diabetes Mellitus, Type 1; Diabetes | 1995 |
[Insulin, glibenclamide plus acarbose in diabetes mellitus?].
Topics: Acarbose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Glyburide | 1995 |
Improved visual evoked potential latencies in poorly controlled diabetic patients after short-term strict metabolic control.
Topics: Adult; Blood Glucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Evoked Potentials, Visua | 1994 |
Regulation of glucose disturbances with glibenclamide in patients with thalassemia.
Topics: Adolescent; Adult; beta-Thalassemia; Blood Glucose; Child; Diabetes Mellitus, Type 1; Female; Glucos | 1998 |
Human anti-murine antibodies interfere with CPR assays performed with commercial kits.
Topics: Aged; Animals; Antibodies; Antibodies, Monoclonal; Artifacts; C-Peptide; Child, Preschool; Diabetes | 2000 |
Exaggerated impact of ATP-sensitive K(+) channels on afferent arteriolar diameter in diabetes mellitus.
Topics: Adenosine Triphosphate; Animals; Arterioles; Benzopyrans; Cyclopentanes; Diabetes Mellitus, Experime | 2000 |
[Proliferative activity of the gastric epithelium: changes due to therapy in patients with association of gastric ulcer and diabetes mellitus].
Topics: Adult; Age Factors; Aged; Data Interpretation, Statistical; Diabetes Complications; Diabetes Mellitu | 2001 |
Glucagon and growth hormone secretion in insulin-treated diabetics: effects of added sulfonylureas.
Topics: Adult; Arginine; Diabetes Mellitus, Type 1; Female; Glucagon; Glyburide; Growth Hormone; Humans; Ins | 1978 |
[The importance of serum insulin determination in the diagnosis and treatment of diabetes mellitus (author's transl)].
Topics: Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diet Therapy; Dose-Response Relationshi | 1975 |
Blood ketone body disappearance rate in diabetics and normals after rapid infusion of dl-3-hydroxybutyrate. Studies before and after diabetic treatment.
Topics: Acetoacetates; Adolescent; Adult; Aged; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Type 1; | 1976 |
Human C-peptide. Part II: Clinical studies.
Topics: C-Peptide; Chromatography, Gel; Diabetes Mellitus; Diabetes Mellitus, Type 1; Glucose; Glyburide; Hu | 1976 |
The dawn phenomenon and diabetes control in treated NIDDM and IDDM patients.
Topics: Blood Glucose; Circadian Rhythm; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Gluca | 1992 |
Metabolic control in diabetic subjects in three Swedish areas with high, medium, and low sales of antidiabetic drugs.
Topics: Administration, Oral; Aged; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Drug Therapy, Comb | 1991 |
Effects of glyburide on in vivo insulin-mediated glucose disposal.
Topics: Adult; Blood Glucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Glucose; Glyburide; Huma | 1990 |
[The correlation of glycohemoglobin (HbA1) with the parameters of blood glucose control during the treatment of diabetes mellitus].
Topics: Adult; Blood Glucose; Chronic Disease; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Drug Th | 1989 |
Effect of glyburide on glycemic control, insulin requirement, and glucose metabolism in insulin-treated diabetic patients.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Glybu | 1987 |
Acute effect of glyburide on insulin sensitivity in type I diabetic patients.
Topics: Blood Glucose; Diabetes Mellitus, Type 1; Drug Synergism; Glyburide; Humans; Insulin; Osmolar Concen | 1987 |
Effect of chronic sulfonylurea treatment on the myocardium of insulin-dependent diabetic rats.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Glucose; Glucose Tolerance Test | 1988 |
Sulfonylureas in insulin-dependent (type I) diabetes: evidence for an extrapancreatic effect in vivo.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Glucose; Glyburide; Humans; Hypoglycemic | 1985 |
Dual actions of sulfonylureas and glyburide. Receptor and post-receptor effects.
Topics: Adipose Tissue; Animals; Cells, Cultured; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mel | 1985 |
Apolipoproteins in diabetes mellitus.
Topics: Adult; Apolipoproteins; Bezafibrate; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus | 1985 |
Mild familial diabetes with dominant inheritance.
Topics: Acetohexamide; Adolescent; Adult; Aged; Blood Glucose; Carbohydrates; Child; Chlorpropamide; Diabete | 1974 |
[Infantile diabetes and treatment with oral hypoglycemizing agents (function tests of the endocrine pancreatic before and after one year of therapy)].
Topics: Child; Child, Preschool; Diabetes Mellitus, Type 1; Female; Glucose Tolerance Test; Glyburide; Human | 1972 |
Glucose-stimulated insulin secretion during "remission" of juvenile diabetes.
Topics: Blood Glucose; Child; Diabetes Mellitus, Type 1; Diet, Diabetic; Glucose Tolerance Test; Glyburide; | 1972 |
Insulin release in children with diet-treated diabetes.
Topics: Adolescent; Blood Glucose; Child; Child, Preschool; Diabetes Mellitus, Type 1; Diabetic Ketoacidosis | 1972 |
[HB 419 (glibenclamide) and possibilities of its combinations in the treatment of diabetes mellitus].
Topics: Diabetes Mellitus; Diabetes Mellitus, Type 1; Drug Synergism; Glyburide; Humans; Insulin; Sulfonylur | 1970 |